Literature DB >> 21219332

Hippocampal betaine/GABA transporter mRNA expression is not regulated by inflammation or dehydration post-status epilepticus.

Nicole M Rowley1, Misty D Smith, John G Lamb, Arne Schousboe, H Steve White.   

Abstract

Seizure activity can alter GABA transporter and osmoprotective gene expression, which may be involved in the pathogenesis of epilepsy. However, the response of the betaine/GABA transporter (BGT1) is unknown. The goal of the present study was to compare the expression of BGT1 mRNA to that of other osmoprotective genes and GABA transporters following status epilepticus (SE). The possible contributory role of dehydration and inflammation was also investigated because both have been shown to be involved in the regulation of GABA transporter and/or osmoprotective gene expression. BGT1 mRNA was increased 24 h post-SE, as were osmoprotective genes. BGT1 was decreased 72 h and 4 weeks post-SE, as were the GABA transporter mRNAs. The mRNA values for osmoprotective genes following 24-h water withdrawal were significantly lower than the values obtained 24 h post-SE despite similarities in their plasma osmolality values. BGT1 mRNA was not altered by lipopolysaccharide-induced inflammation while the transcription factor tonicity-responsive enhancer binding protein and the GABA transporters 1 and 3 were. These results suggest that neither plasma osmolality nor inflammation fully account for the changes seen in BGT1 mRNA expression post-SE. However, it is evident that BGT1 mRNA expression is altered by SE and displays a temporal pattern with similarities to both GABA and osmolyte transporters. Further investigation of BGT1 regulation in the brain is warranted.
© 2011 The Authors. Journal of Neurochemistry © 2011 International Society for Neurochemistry.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21219332      PMCID: PMC3057375          DOI: 10.1111/j.1471-4159.2011.07174.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  78 in total

Review 1.  Cell volume regulation: osmolytes, osmolyte transport, and signal transduction.

Authors:  F Wehner; H Olsen; H Tinel; E Kinne-Saffran; R K H Kinne
Journal:  Rev Physiol Biochem Pharmacol       Date:  2003-04-04       Impact factor: 5.545

2.  Subcellular redistribution of the renal betaine transporter during hypertonic stress.

Authors:  Stephen A Kempson; Vaibhave Parikh; Lixuan Xi; Shaoyou Chu; Marshall H Montrose
Journal:  Am J Physiol Cell Physiol       Date:  2003-07-02       Impact factor: 4.249

3.  Modification of seizure activity by electrical stimulation. II. Motor seizure.

Authors:  R J Racine
Journal:  Electroencephalogr Clin Neurophysiol       Date:  1972-03

4.  Stimulus-induced changes in extracellular Na+ and Cl- concentration in relation to changes in the size of the extracellular space.

Authors:  I Dietzel; U Heinemann; G Hofmeier; H D Lux
Journal:  Exp Brain Res       Date:  1982       Impact factor: 1.972

5.  Changes in GABA transporters in the rat hippocampus after kainate-induced neuronal injury: decrease in GAT-1 and GAT-3 but upregulation of betaine/GABA transporter BGT-1.

Authors:  Xiao-Ming Zhu; Wei-Yi Ong
Journal:  J Neurosci Res       Date:  2004-08-01       Impact factor: 4.164

6.  Patterns of seizures, hippocampal injury and neurogenesis in three models of status epilepticus in galanin receptor type 1 (GalR1) knockout mice.

Authors:  A Mazarati; X Lu; S Shinmei; H Badie-Mahdavi; T Bartfai
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

7.  Anticonvulsant properties of betaine.

Authors:  W J Freed; J C Gillin; R J Wyatt
Journal:  Epilepsia       Date:  1979-06       Impact factor: 5.864

8.  Transcription factor tonicity-responsive enhancer-binding protein (TonEBP) which transactivates osmoprotective genes is expressed and upregulated following acute systemic hypertonicity in neurons in brain.

Authors:  M L Loyher; M Mutin; S K Woo; H M Kwon; M L Tappaz
Journal:  Neuroscience       Date:  2004       Impact factor: 3.590

9.  Expression of plasma membrane GABA transporters but not of the vesicular GABA transporter in dentate granule cells after kainic acid seizures.

Authors:  Günther Sperk; Christoph Schwarzer; Jutta Heilman; Sabine Furtinger; Richard J Reimer; Robert H Edwards; Nathan Nelson
Journal:  Hippocampus       Date:  2003       Impact factor: 3.899

10.  Loss of NFAT5 results in renal atrophy and lack of tonicity-responsive gene expression.

Authors:  Cristina López-Rodríguez; Christopher L Antos; John M Shelton; James A Richardson; Fangming Lin; Tatiana I Novobrantseva; Roderick T Bronson; Peter Igarashi; Anjana Rao; Eric N Olson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-24       Impact factor: 11.205

View more
  4 in total

1.  Betaine in the Brain: Characterization of Betaine Uptake, its Influence on Other Osmolytes and its Potential Role in Neuroprotection from Osmotic Stress.

Authors:  Leena S Knight; Quinn Piibe; Ian Lambie; Christopher Perkins; Paul H Yancey
Journal:  Neurochem Res       Date:  2017-09-16       Impact factor: 3.996

2.  Combined effect between two functional polymorphisms of SLC6A12 gene is associated with temporal lobe epilepsy.

Authors:  Jingyun Li; Hua Lin; Fenghe Niu; Xilin Zhu; Ning Shen; Xin Wang; Liping Li; Aihua Liu; Xiaopan Wu; Wei Sun; Yuping Wang; Ying Liu
Journal:  J Genet       Date:  2015-12       Impact factor: 1.166

3.  Myo-inositol treatment and GABA-A receptor subunit changes after kainate-induced status epilepticus.

Authors:  Revaz Solomonia; Nana Gogichaishvili; Maia Nozadze; Eka Lepsveridze; David Dzneladze; Tamar Kiguradze
Journal:  Cell Mol Neurobiol       Date:  2012-09-18       Impact factor: 5.046

4.  The protective effect of myo-inositol on hippocamal cell loss and structural alterations in neurons and synapses triggered by kainic acid-induced status epilepticus.

Authors:  Nato Kotaria; Maia Kiladze; Mzia G Zhvania; Nadezhda J Japaridze; Tamar Bikashvili; Revaz O Solomonia; Tamar Bolkvadze
Journal:  Cell Mol Neurobiol       Date:  2013-04-09       Impact factor: 5.046

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.